Rui‐Cheng Xu
-
- Ion Transport and Channel Regulation 6
- ATP Synthase and ATPases Research 4
- Mitochondrial Function and Pathology 3
- TGF-β signaling in diseases 2
- Ion channel regulation and function 2
- Retinoids in leukemia and cellular processes 2
-
- Cancer, Hypoxia, and Metabolism 3
-
- High Altitude and Hypoxia 2
- Co-authors
- Fengmei WangShuping WeiHuiyan SunWencheng ZhangZhongwei XuXiaoyi ChenXiangyan MengXiaohan Jin
- Journals
- PLoS ONE (1 paper)Biochemical and Biophysical Research Communications (1 paper)Biophysical Journal (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Rui‐Cheng Xu
21 papers receiving 518 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 355
- Cancer Research 75
- Toxicology 16
- Cellular and Molecular Neuroscience 67
- Pharmacology 27
Countries citing papers authored by Rui‐Cheng Xu
This map shows the geographic impact of Rui‐Cheng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui‐Cheng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui‐Cheng Xu more than expected).
Fields of papers citing papers by Rui‐Cheng Xu
This network shows the impact of papers produced by Rui‐Cheng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui‐Cheng Xu. The network helps show where Rui‐Cheng Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rui‐Cheng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2020 | 21 | |
| 3 | 2019 | 18 | |
| 4 | 2018 | 28 | |
| 5 | 2018 | 53 | |
| 6 | 2017 | 17 | |
| 7 | 2017 | 12 | |
| 8 | 2015 | 38 | |
| 9 | 2015 | 13 | |
| 10 | 2014 | 22 | |
| 11 | [The effects of intermittent hypobaric hypoxia on myocardial ischemia/reperfusion injury and ZFP580 expression]. | 2014 | 1 |
| 12 | 2013 | 40 | |
| 13 | Growth inhibition and G_2/M phase arrest in human ovarian cancer SKOV_3 cells induced by pseudolaric acid B | 2012 | 1 |
| 14 | 2011 | 40 | |
| 15 | 2011 | 10 | |
| 16 | The linkage between cell cycle S phase arrest and apoptosis on human hepatocellular carcinoma HepG2 induced by Na~+,K~+-ATPase inhibitors via regulating proteins associated with cell cycle | 2010 | 1 |
| 17 | 2010 | 74 | |
| 18 | [Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism]. | 2010 | 3 |
| 19 | 2010 | 53 | |
| 20 | 1995 | 67 |
About Rui‐Cheng Xu
Rui‐Cheng Xu is a scholar working on Cancer Research, Molecular Biology and Biochemistry, having authored 21 papers that have together received 522 indexed citations. Recurring topics across this work include Ion Transport and Channel Regulation (6 papers), ATP Synthase and ATPases Research (4 papers), Mitochondrial Function and Pathology (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), TGF-β signaling in diseases (2 papers), Ion channel regulation and function (2 papers), Retinoids in leukemia and cellular processes (2 papers) and High Altitude and Hypoxia (2 papers). The work is most often cited by research in Molecular Biology (355 citations), Cancer Research (75 citations) and Toxicology (16 citations). Rui‐Cheng Xu has collaborated with scholars based in China and United States. Frequent co-authors include Fengmei Wang, Shuping Wei, Huiyan Sun, Wencheng Zhang, Zhongwei Xu, Zhongwei Xu, Xiaoyi Chen, Xiangyan Meng, Xiaohan Jin and Shixiang Cheng. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Biophysical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.